현재 페이지 준비중입니다.

현재 페이지는 준비중입니다.
빠른 시일 내에 더욱 나은 모습으로 찾아뵙겠습니다.
감사합니다.

JD Bioscience

본문 바로가기
사이트 내 전체검색
닫기

Heart disease

  • Heart disease, a leading cause of death globally, can be categorized into ischemic heart disease, cardiomyopathy, and myocarditis.

    Different types of medication are available to treat heart disease, for example, cholesterol-lowering medications, beta-blockers, nitroglycerin, and calcium channel blockers. However, none of these can rescue the function of cardiomyocytes once heart failure is in progression.

  • Ischemic heart disease is involved in the reduction of blood flow due to the accumulation of fatty deposits in the coronary arteries. Cardiomyopathy, including hypertrophic or dilated cardiomyopathy, is a disease of the heart muscle that can occur due to various risk factors. Finally, myocarditis is characterized by the inflammation of the heart muscle, which often occurs due to a viral infection. All of these can ultimately lead to fatal heart failure.

Mechanism of action of JDB’s asset

Mechanism of
action of JDB’s asset

  • JDB is developing a novel drug candidate for heart disease that can rescue heart function at a cellular level, and can eventually help improving heart function.

Compound information is yet to be revealed

회원로그인

회원가입

사이트 정보

회사명 : 회사명 / 대표 : 대표자명
주소 : OO도 OO시 OO구 OO동 123-45
사업자 등록번호 : 123-45-67890
전화 : 02-123-4567 팩스 : 02-123-4568
통신판매업신고번호 : 제 OO구 - 123호
개인정보관리책임자 : 정보책임자명

  • 게시물이 없습니다.

접속자집계

오늘
17
어제
92
최대
218
전체
12,930
Privacy policy

COPYRIGHT(C) 2021 JD BIOSCIENCE INC. ALL RIGHT RESERVED